ezetimibe has been researched along with Crigler Najjar Syndrome in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Blankestijn, M; Capkova, N; Dvorak, A; Jonker, JW; van de Peppel, IP; Verkade, HJ; Vitek, L | 1 |
| Beuers, U; Bosma, PJ; de Knegt, RJ; de Waart, DR; Duijst, S; Finel, M; Montenegro-Miranda, PS; Sneitz, N; Ten Bloemendaal, L | 1 |
2 other study(ies) available for ezetimibe and Crigler Najjar Syndrome
| Article | Year |
|---|---|
Induction of fecal cholesterol excretion is not effective for the treatment of hyperbilirubinemia in Gunn rats.
Topics: Animals; Bile; Bile Acids and Salts; Bilirubin; Chenodeoxycholic Acid; Cholesterol; Crigler-Najjar Syndrome; Dietary Fats; Ezetimibe; Feces; Haptoglobins; Hydrocarbons, Fluorinated; Hyperbilirubinemia; Intestines; Lipids; Liver X Receptors; Male; PPAR delta; Random Allocation; Rats; Rats, Gunn; Receptors, Cytoplasmic and Nuclear; Sulfonamides | 2021 |
Ezetimibe: A biomarker for efficacy of liver directed UGT1A1 gene therapy for inherited hyperbilirubinemia.
Topics: Animals; Azetidines; Bilirubin; Biomarkers; Crigler-Najjar Syndrome; Disease Models, Animal; Ezetimibe; Female; Genetic Therapy; Genetic Vectors; Glucuronosyltransferase; Humans; Liver; Liver Diseases; Male; Random Allocation; Rats; Rats, Gunn | 2012 |